NR2F6
Basic information
Region (hg38): 19:17231883-17245919
Previous symbols: [ "ERBAL2" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NR2F6 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 25 | 26 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 25 | 1 | 0 |
Variants in NR2F6
This is a list of pathogenic ClinVar variants found in the NR2F6 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-17232362-G-A | not specified | Uncertain significance (Jun 27, 2022) | ||
19-17232366-C-T | not specified | Uncertain significance (Jun 07, 2023) | ||
19-17232387-T-C | not specified | Uncertain significance (Jan 24, 2023) | ||
19-17232482-G-A | not specified | Uncertain significance (Apr 06, 2023) | ||
19-17232483-C-T | not specified | Uncertain significance (Dec 20, 2023) | ||
19-17232522-G-A | not specified | Uncertain significance (Jun 13, 2024) | ||
19-17232548-C-T | not specified | Uncertain significance (Mar 15, 2024) | ||
19-17232566-G-A | not specified | Uncertain significance (Apr 26, 2023) | ||
19-17232570-C-T | not specified | Uncertain significance (Feb 28, 2024) | ||
19-17235535-A-T | not specified | Uncertain significance (Sep 22, 2023) | ||
19-17235552-T-C | not specified | Uncertain significance (May 03, 2023) | ||
19-17235595-C-A | not specified | Uncertain significance (Dec 19, 2022) | ||
19-17235639-G-C | not specified | Uncertain significance (Dec 03, 2021) | ||
19-17235654-G-A | not specified | Uncertain significance (Dec 27, 2023) | ||
19-17235672-G-A | not specified | Uncertain significance (May 08, 2023) | ||
19-17235699-G-A | not specified | Uncertain significance (Mar 20, 2023) | ||
19-17235715-G-C | not specified | Uncertain significance (Jun 02, 2024) | ||
19-17235844-T-C | not specified | Uncertain significance (Jan 17, 2024) | ||
19-17235906-G-A | not specified | Uncertain significance (Apr 26, 2023) | ||
19-17235961-G-A | not specified | Uncertain significance (Jun 27, 2023) | ||
19-17235985-C-T | not specified | Uncertain significance (Oct 25, 2022) | ||
19-17235993-G-A | not specified | Uncertain significance (May 06, 2024) | ||
19-17235996-C-G | not specified | Uncertain significance (Dec 15, 2022) | ||
19-17236011-G-A | not specified | Uncertain significance (Oct 14, 2023) | ||
19-17236044-G-A | not specified | Uncertain significance (Dec 31, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NR2F6 | protein_coding | protein_coding | ENST00000291442 | 4 | 14058 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.451 | 0.543 | 125726 | 0 | 5 | 125731 | 0.0000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.87 | 115 | 187 | 0.615 | 0.0000112 | 2525 |
Missense in Polyphen | 57 | 107.58 | 0.52986 | 1160 | ||
Synonymous | -2.20 | 111 | 85.2 | 1.30 | 0.00000527 | 873 |
Loss of Function | 2.32 | 2 | 9.87 | 0.203 | 4.25e-7 | 132 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000352 | 0.0000352 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transcription factor predominantly involved in transcriptional repression. Binds to promoter/enhancer response elements that contain the imperfect 5'-AGGTCA-3' direct or inverted repeats with various spacings which are also recognized by other nuclear hormone receptors. Involved in modulation of hormonal responses. Represses transcriptional activity of the lutropin-choriogonadotropic hormone receptor/LHCGR gene, the renin/REN gene and the oxytocin-neurophysin/OXT gene. Represses the triiodothyronine-dependent and -independent transcriptional activity of the thyroid hormone receptor gene in a cell type- specific manner. The corepressing function towards thyroid hormone receptor beta/THRB involves at least in part the inhibition of THRB binding to triiodothyronine response elements (TREs) by NR2F6. Inhibits NFATC transcription factor DNA binding and subsequently its transcriptional activity. Acts as transcriptional repressor of IL-17 expression in Th-17 differentiated CD4(+) T cells and may be involved in induction and/or maintenance of peripheral immunological tolerance and autoimmunity. Involved in development of forebrain circadian clock; is required early in the development of the locus coeruleus (LC). {ECO:0000269|PubMed:10644740, ECO:0000269|PubMed:10713182, ECO:0000269|PubMed:11682620, ECO:0000269|PubMed:18701084}.;
- Pathway
- NHR;Nuclear Receptors;IL-6 signaling pathway;Gene expression (Transcription);Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription
(Consensus)
Recessive Scores
- pRec
- 0.161
Haploinsufficiency Scores
- pHI
- 0.188
- hipred
- Y
- hipred_score
- 0.716
- ghis
- 0.638
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.992
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Nr2f6
- Phenotype
- integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;transcription initiation from RNA polymerase II promoter;signal transduction;intracellular receptor signaling pathway;entrainment of circadian clock by photoperiod;steroid hormone mediated signaling pathway;neuron development;detection of temperature stimulus involved in sensory perception of pain
- Cellular component
- nucleus;nucleoplasm
- Molecular function
- RNA polymerase II distal enhancer sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;steroid hormone receptor activity;nuclear receptor activity;protein binding;zinc ion binding;sequence-specific DNA binding